Related Articles
Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain
The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress
The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain
Cannabinoid CB2 receptors are involved in the regulation of fibrogenesis during skin wound repair in mice
Spinal cord stimulation reduces cardiac pain through microglial deactivation in rats with chronic myocardial ischemia